Sort
21,281 grants matching “influenza”
Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention
$633,875Steve W Cole · University Of California Los Angeles · R01 · FY2024 · AG
Virulence Determinants in Staphylococcus Bacteremia
$633,847Steven R. Gill · University Of Rochester · R01 · FY2012 · AI
Maternal Immunity
$633,717Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2025 · AI
H. influenzae: Role of Sialic Acid in Virulence
$633,704Michael A. Apicella · University Of Iowa · R01 · FY2014 · AI
H. influenzae: Role of Sialic Acid in Virulence
$633,704Michael A. Apicella · University Of Iowa · R01 · FY2012 · AI
Immunology Team Contributions to the LSB
$633,676Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Rapid Manufacturing of a Universal Flu Vaccine Using TMV-conjugated Centralized Antigens
$633,642Eric A Weaver · University Of Nebraska Lincoln · R01 · FY2021 · AI
Arsenic and immune response to influenza vaccination in pregnant women and newborns
$633,416Christopher D Heaney · Johns Hopkins University · R01 · FY2019 · ES
Neutralization Fingerprinting Analysis of Polyclonal Antibody Responses against HIV-1
$633,392Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2018 · AI
Systems Biology Approach to Analysis of Vaccine Response in Healthy Individuals
$633,368Anna Karolina Palucka · Baylor Research Institute · U19 · FY2011 · AI
B cell immunity in HIV exposed uninfected infants in Kenya
$633,365Arlene Dent · Case Western Reserve University · R01 · FY2012 · AI
Longitudinal analysis to determine persistence of T cell responses induced by SARS-CoV-2 vaccination, natural infection with SARS-CoV-2, and human common cold coronaviruses
$633,253Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2025 · AI
Impact of a Community Care Intervention to Address Inequities in COVID-19 and Influenza Vaccination Among Adults Suffering from Disproportionate Chronic Disease
$633,199Marielena Lara · Rand Corporation · R01 · FY2023 · MD
Lipid nanoparticles as novel adjuvants inducing effective T follicular helper cell and humoral immune responses
$633,178Norbert Pardi · University Of Pennsylvania · R01 · FY2021 · AI
Host dependence of influenza A virus reassortment
$633,061Anice C Lowen · Emory University · R01 · FY2020 · AI
Biology, Evolution and Pathogenesis of Influenza A Virus
$632,934Jack R Bennink · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Virus Induction of Primary and Memory B- and T-Cell Responses
$632,934Jack R Bennink · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Forecasting tipping points in emerging and re-emerging infectious diseases
$632,839John M Drake · University Of Georgia · U01 · FY2017 · GM
Structure and Replication of Hepatitis Delta Virus
$632,726John Marston Taylor · Research Inst Of Fox Chase Can Ctr · R01 · FY2008 · AI
Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
$632,725Marian L Kohut · Iowa State University · R01 · FY2025 · AI
EFFICACY OF OSELTAMIVIR IN REDUCING DURATION OF ILLNESS, VIRAL SHEDDING & TRANSIS
$632,629W. Abdullah Brooks · International Ctr/Diarrhoeal Dis Res · U01 · FY2010 · IP
The influence of evolutionary landscapes on protective antibody development
$632,397Timothy Andrew Whitehead · University Of Colorado · R01 · FY2020 · AI
Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumonia
$632,294Bria M Coates · Lurie Children'S Hospital Of Chicago · R01 · FY2025 · HL
RNA:protein interactions that dictate the success of influenza virus infection
$632,278Andrew Mehle · University Of Wisconsin-Madison · R01 · FY2024 · AI
Innate NLRC4 signaling controls adaptive immune responses
$632,133Fayyaz S. Sutterwala · Cedars-Sinai Medical Center · R01 · FY2025 · AI